Podcast Episodes
Back to SearchWhat does current evidence show about acetaminophen use in pregnancy?
Episode 602
A large Lancet meta-analysis found no clinically meaningful association between prenatal acetaminophen exposure and autism, ADHD, or intellectual dis…
6 months, 3 weeks ago
Should clinicians routinely ask patients about firearm access?
Episode 601
Firearm ownership has surged in the U.S., yet safety discussions remain uncommon in clinical care. An NEJM article supports routine, nonpolitical fir…
6 months, 4 weeks ago
Are missed 2-month vaccines the strongest warning sign for future MMR refusal?
Episode 600
A large U.S. cohort study found that children who were late for routine 2- or 4-month immunizations were six to seven times more likely to miss MMR v…
7 months ago
Do GLP-1 weight-loss drugs also reduce asthma attacks in teens?
Episode 599
New real-world data suggest that GLP-1 receptor agonists used for adolescent obesity are associated with roughly half the rate of asthma exacerbation…
7 months ago
What happens to factor Xa reversal strategies now that andexanet is leaving the U.S.?
Episode 598
The FDA has issued a major safety alert on andexanet alfa, used to reverse factor Xa inhibitors, after post-marketing data and the ANNEXA-I trial sho…
7 months, 2 weeks ago
HER2+ Lung Cancer at ESMO 2025
Episode 597
Drs. Yu and Herzberg discuss recent developments in HER2- and EGFR-targeted therapies for lung cancer, focusing on clinical trial results at ESMO 202…
7 months, 2 weeks ago
HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations
Episode 596
Drs. Herzberg and Yu continue their discussion on emerging clinical data presented at ESMO and WCLC 2025. They highlight recent advancements in HER2-…
7 months, 3 weeks ago
HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained
Episode 595
Drs. Herzberg and Yu explore emerging clinical data from the 2025 meetings of the European Society For Medical Oncology (ESMO) and World Conference o…
7 months, 3 weeks ago
Does tirzepatide offer comparable cardiovascular safety to GLP-1 therapy in diabetes?
Episode 594
A large cardiovascular outcomes trial in high-risk adults with type 2 diabetes showed that a dual incretin therapy was noninferior to an established …
7 months, 3 weeks ago
Veterans and Interstitial Lung Disease: Risk Prediction Models and Early Detection
Episode 593
Drs. Kaul and Adegunsoye discuss advanced technologies to improve early detection and treatment of interstitial lung disease in veterans, with innova…
7 months, 3 weeks ago